These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1736833)

  • 41. A new look at induction chemotherapy in locally advanced head and neck cancer.
    Vermorken JB
    Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881
    [No Abstract]   [Full Text] [Related]  

  • 42. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck.
    Decker DA; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh JJ; Weaver A; Al-Sarraf M
    Cancer; 1983 Apr; 51(8):1353-5. PubMed ID: 6681726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
    Grimaldi A; Merlano M; Gardin G; Rosso R
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1539-40. PubMed ID: 2439343
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck.
    Klocker J; Sabitzer H; Raunik W; Wieser S; Schumer J
    Cancer Lett; 1998 Sep; 131(1):113-5. PubMed ID: 9839626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy for head and neck cancer: the addition of Bcl-2 inhibitors.
    Lo Russo L; Lo Muzio L
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1325-33. PubMed ID: 19943204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies.
    Aich RK; Deb AR; Ray A
    J Cancer Res Ther; 2005; 1(1):46-50. PubMed ID: 17998626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal rearrangements in lymphocytes of head and neck squamous cell carcinoma treated with chemotherapeutic agents.
    Desai B; Gadhia P
    Neoplasma; 2012; 59(4):463-8. PubMed ID: 22489702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cisplatin, vindesine and hyaluronidase combined with simultaneous radiotherapy of advanced head and neck tumors].
    Schumer J; Klocker J; Tidstrand J; Rab B; Allmayer H
    Onkologie; 1990 Aug; 13(4):310-2. PubMed ID: 2234785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck.
    Inuyama Y; Fujii M; Tanaka J; Takaoka T; Hosoda H; Kohno N; Saito S
    Auris Nasus Larynx; 1986; 13(3):191-8. PubMed ID: 2439061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination chemotherapy with CDDP, 5-FU and PEP in head and neck malignant tumors.
    Furusaka T; Kida A; Iizuka N; Kikuchi K; Tomita H
    Auris Nasus Larynx; 1986; 13 Suppl 1():S135-42. PubMed ID: 2429646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CPE chemotherapy for tongue carcinoma--clinical effects and side effects].
    Yamamoto C; Kutsuki M; Nishikawa M; Nishimura K; Inoda H; Takigami K; Mori M; Yamaguchi Y; Yoshitake K
    Gan To Kagaku Ryoho; 1997 May; 24(7):843-7. PubMed ID: 9170523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
    Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J
    Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Head and neck cancer].
    Inuyama Y; Fukuda S; Satoh N
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1902-9. PubMed ID: 9350234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of a combination of low dose cisplatin (DDP) and bolus 5-fluorouracil (FU) in recurrent and metastatic squamous cell carcinoma of the head and neck.
    Cognetti F; Clerico M; Vermorken J; Van Rymenant M; Rossi A; Kirkpatrick A; Dalesic O; Clavel M
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):891-2. PubMed ID: 3770044
    [No Abstract]   [Full Text] [Related]  

  • 55. A nontoxic adjuvant treatment for advanced head and neck cancer.
    Spaulding MB; Vasquez J; Khan A; Sundquist N; Lorè JM
    Arch Otolaryngol; 1983 Dec; 109(12):789-91. PubMed ID: 6685474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trajectory and risk factors for chemotherapy-induced nausea and vomiting in Asian patients with head and neck cancer.
    Chan A; Shwe M; Gan Y; Yap K; Chew L; Lim WT
    Head Neck; 2015 Sep; 37(9):1349-57. PubMed ID: 24816644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin and 5-fluorouracil in squamous cell carcinoma of the head and neck previously responding to cisplatin and 5-fluorouracil.
    Benasso M; Numico G; Merlano M
    Eur J Cancer; 1997 Feb; 33(2):318-9. PubMed ID: 9135510
    [No Abstract]   [Full Text] [Related]  

  • 58. [5-FU+CDDP(FP) +cetuximab in recurrence/metastasis head and neck cancer].
    Yamazaki T; Tahara M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():562-6. PubMed ID: 25831823
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of advanced squamous-cell carcinoma of the head and neck with a combination of cisplatin, vinblastine, and bleomycin.
    Woods RL; Fox RM; Kaye SB; Coates AS; Tattersall MH
    Med J Aust; 1984 Sep; 141(5):284-6. PubMed ID: 6206382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized trial of neoadjuvant chemotherapy with cisplatin plus 5-fluorouracil, with or without leucovorin, in locally advanced head and neck cancer.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Muñoz A; Pardal JL
    Ann Oncol; 1997 Jul; 8(7):713-4. PubMed ID: 9296230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.